In Vivo Pharmacokinetic Evaluation and In Vitro-In Vivo Correlation of a Sulphated Locust Bean Gum and Cationic Guar Gum Polyelectrolyte Complex Based Controlled Release Tablet of Losartan Potassium in Rabbits

Background: Losartan potassium (LP), a widely prescribed angiotensin II receptor blocker, is characterized by low oral bioavailability (~33%) and a short elimination half life (1.5-2.5 h), which together necessitate frequent daily dosing. A controlled-release (CR) tablet formulation of LP (LPC), based on a polyelectrolyte complex (PEC) of sulphated locust bean gum (SLBG) and cationic guar gum (CGG), was previously optimised by Box-Behnken design and shown to sustain in vitro drug release for 12 h. The present study evaluated the in vivo performance of a rabbit equivalent dose PEC tablet (RLPC) and established an in vitro–in vivo correlation (IVIVC). Methods: The rabbit equivalent dose was estimated by the body surface area conversion method, and RLPC tablets were prepared by proportionate downscaling of the optimised LPC formula. A single dose, parallel group pharmacokinetic study was conducted in healthy male rabbits (n = 6/group) that received either a pure LP dispersion (reference) or RLPC tablets (test) by oral gavage. Serial blood samples were withdrawn from the marginal ear vein over 24 h, and plasma LP was quantified by a validated HPLC-PDA method. Non-compartmental pharmacokinetic parameters were derived, group differences were tested by an unpaired Student’s t-test, and a Level A IVIVC was constructed between in vitro fraction dissolved and in vivo fraction absorbed. Results: RLPC produced a lower peak plasma concentration (Cmax 304.33 vs 356.42 ng/mL) with a markedly delayed time to peak (Tmax 6 vs 1 h) relative to the pure drug. Systemic exposure was significantly greater for RLPC, with AUC0–∞ rising from 1113.81 to 4201.65 ng·h/mL (~3.8-fold) and mean residence time increasing from 3.41 to 9.52 h (p < 0.05). Elimination rate constant and half life were not significantly different between treatments (p > 0.05), indicating that the intrinsic elimination of LP was unaffected by the PEC matrix. A strong Level A IVIVC was obtained (R² = 0.9919). Conclusion: The PEC formed between SLBG and CGG effectively sustained the in vivo release of losartan potassium, producing a controlled release pharmacokinetic profile with a good in vitro–in vivo relationship, supporting its potential as a release retarding matrix for oral controlled release drug delivery.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-16
DOI
https://doi.org/10.25258/ijddt.16.80s.73
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In Vivo Pharmacokinetic Evaluation and In Vitro-In Vivo Correlation of a Sulphated Locust Bean Gum and Cationic Guar Gum Polyelectrolyte Complex Based Controlled Release Tablet of Losartan Potassium in Rabbits

G. Girija Sankar, D. Purnima Yadav, N. Lakshmi Prasanthi, K. V. Ramana Murthy
International Journal of Drug Delivery Technology
Advanced Drug Delivery Systems
article

In Vivo Pharmacokinetic Evaluation and In Vitro-In Vivo Correlation of a Sulphated Locust Bean Gum and Cationic Guar Gum Polyelectrolyte Complex Based Controlled Release Tablet of Losartan Potassium in Rabbits

G. Girija Sankar, D. Purnima Yadav, N. Lakshmi Prasanthi, K. V. Ramana Murthy
article en

Abstract

Background: Losartan potassium (LP), a widely prescribed angiotensin II receptor blocker, is characterized by low oral bioavailability (~33%) and a short elimination half life (1.5-2.5 h), which together necessitate frequent daily dosing. A controlled-release (CR) tablet formulation of LP (LPC), based on a polyelectrolyte complex (PEC) of sulphated locust bean gum (SLBG) and cationic guar gum (CGG), was previously optimised by Box-Behnken design and shown to sustain in vitro drug release for 12 h. The present study evaluated the in vivo performance of a rabbit equivalent dose PEC tablet (RLPC) and established an in vitro–in vivo correlation (IVIVC). Methods: The rabbit equivalent dose was estimated by the body surface area conversion method, and RLPC tablets were prepared by proportionate downscaling of the optimised LPC formula. A single dose, parallel group pharmacokinetic study was conducted in healthy male rabbits (n = 6/group) that received either a pure LP dispersion (reference) or RLPC tablets (test) by oral gavage. Serial blood samples were withdrawn from the marginal ear vein over 24 h, and plasma LP was quantified by a validated HPLC-PDA method. Non-compartmental pharmacokinetic parameters were derived, group differences were tested by an unpaired Student’s t-test, and a Level A IVIVC was constructed between in vitro fraction dissolved and in vivo fraction absorbed. Results: RLPC produced a lower peak plasma concentration (Cmax 304.33 vs 356.42 ng/mL) with a markedly delayed time to peak (Tmax 6 vs 1 h) relative to the pure drug. Systemic exposure was significantly greater for RLPC, with AUC0–∞ rising from 1113.81 to 4201.65 ng·h/mL (~3.8-fold) and mean residence time increasing from 3.41 to 9.52 h (p < 0.05). Elimination rate constant and half life were not significantly different between treatments (p > 0.05), indicating that the intrinsic elimination of LP was unaffected by the PEC matrix. A strong Level A IVIVC was obtained (R² = 0.9919). Conclusion: The PEC formed between SLBG and CGG effectively sustained the in vivo release of losartan potassium, producing a controlled release pharmacokinetic profile with a good in vitro–in vivo relationship, supporting its potential as a release retarding matrix for oral controlled release drug delivery.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Andhra University (IN)
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon